Truist Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $144M | Buy |
941,818
+54,522
| +6% | +$8.36M | 0.19% | 103 |
|
|
2025
Q4 | $122M | Buy |
887,296
+54,682
| +7% | +$7.16M | 0.16% | 123 |
|
|
2025
Q3 | $107M | Buy |
832,614
+34,147
| +4% | +$4.17M | 0.14% | 144 |
|
|
2025
Q2 | $96.6M | Buy |
798,467
+28,726
| +4% | +$3.24M | 0.14% | 144 |
|
|
2025
Q1 | $85.8M | Sell |
769,741
-1,914
| -0.2% | -$204K | 0.14% | 153 |
|
|
2024
Q4 | $75.1M | Buy |
771,655
+27,092
| +4% | +$2.89M | 0.12% | 166 |
|
|
2024
Q3 | $85.6M | Sell |
744,563
-5,842
| -0.8% | -$663K | 0.13% | 147 |
|
|
2024
Q2 | $79.9M | Sell |
750,405
-5,657
| -0.7% | -$568K | 0.12% | 171 |
|
|
2024
Q1 | $73.1M | Sell |
756,062
-74,303
| -9% | -$7.62M | 0.11% | 178 |
|
|
2023
Q4 | $83.8M | Sell |
830,365
-33,494
| -4% | -$3.23M | 0.13% | 151 |
|
|
2023
Q3 | $88M | Buy |
863,859
+85,075
| +11% | +$8.64M | 0.15% | 147 |
|
|
2023
Q2 | $78.6M | Sell |
778,784
-52,632
| -6% | -$5.26M | 0.13% | 157 |
|
|
2023
Q1 | $76.5M | Sell |
831,416
-124,363
| -13% | -$10.9M | 0.13% | 162 |
|
|
2022
Q4 | $86.7M | Sell |
955,779
-10,416
| -1% | -$877K | 0.15% | 142 |
|
|
2022
Q3 | $73.4M | Sell |
966,195
-8,089
| -0.8% | -$671K | 0.14% | 146 |
|
|
2022
Q2 | $82.4M | Sell |
974,284
-120,349
| -11% | -$10.6M | 0.15% | 140 |
|
|
2022
Q1 | $96.1M | Buy |
1,094,633
+76,233
| +7% | +$6.6M | 0.15% | 141 |
|
|
2021
Q4 | $89.1M | Sell |
1,018,400
-16,861
| -2% | -$1.4M | 0.14% | 166 |
|
|
2021
Q3 | $84.7M | Buy |
1,035,261
+35,423
| +4% | +$3.19M | 0.14% | 163 |
|
|
2021
Q2 | $91.2M | Buy |
999,838
+31,103
| +3% | +$2.77M | 0.15% | 148 |
|
|
2021
Q1 | $82.8M | Buy |
968,735
+76,499
| +9% | +$6.86M | 0.14% | 157 |
|
|
2020
Q4 | $84.3M | Buy |
892,236
+54,765
| +7% | +$4.79M | 0.16% | 143 |
|
|
2020
Q3 | $72.8M | Buy |
837,471
+6,719
| +0.8% | +$582K | 0.16% | 142 |
|
|
2020
Q2 | $72.6M | Buy |
830,752
+27,160
| +3% | +$2.34M | 0.16% | 145 |
|
|
2020
Q1 | $66.3M | Buy |
803,592
+52,164
| +7% | +$4.65M | 0.17% | 133 |
|
|
2019
Q4 | $71.2M | Buy |
751,428
+604,435
| +411% | +$54.2M | 0.14% | 156 |
|
|
2019
Q3 | $12.8M | Sell |
146,993
-3,816
| -3% | -$343K | 0.22% | 115 |
|
|
2019
Q2 | $13.8M | Sell |
150,809
-25,167
| -14% | -$2.13M | 0.24% | 106 |
|
|
2019
Q1 | $15.2M | Sell |
175,976
-13,058
| -7% | -$1.05M | 0.27% | 98 |
|
|
2018
Q4 | $14.5M | Sell |
189,034
-6,231
| -3% | -$485K | 0.3% | 91 |
|
|
2018
Q3 | $15.1M | Sell |
195,265
-2,563
| -1% | -$189K | 0.27% | 97 |
|
|
2018
Q2 | $13.4M | Sell |
197,828
-32,699
| -14% | -$2.26M | 0.25% | 99 |
|
|
2018
Q1 | $16.7M | Sell |
230,527
-37,119
| -14% | -$2.83M | 0.32% | 85 |
|
|
2017
Q4 | $20.1M | Sell |
267,646
-80,092
| -23% | -$6.04M | 0.38% | 68 |
|
|
2017
Q3 | $26.8M | Sell |
347,738
-10,442
| -3% | -$789K | 0.52% | 43 |
|
|
2017
Q2 | $26.8M | Sell |
358,180
-6,319
| -2% | -$448K | 0.53% | 43 |
|
|
2017
Q1 | $24.3M | Buy |
364,499
+27,845
| +8% | +$1.86M | 0.49% | 45 |
|
|
2016
Q4 | $22M | Buy |
336,654
+9,327
| +3% | +$605K | 0.45% | 51 |
|
|
2016
Q3 | $23.2M | Buy |
327,327
+3,074
| +0.9% | +$224K | 0.48% | 49 |
|
|
2016
Q2 | $24M | Buy |
324,253
+10,740
| +3% | +$742K | 0.5% | 44 |
|
|
2016
Q1 | $20.4M | Buy |
313,513
+16,763
| +6% | +$1.14M | 0.53% | 43 |
|
|
2015
Q4 | $22.9M | Sell |
296,750
-13,912
| -4% | -$1.11M | 0.59% | 37 |
|
|
2015
Q3 | $25.6M | Sell |
310,662
-11,667
| -4% | -$1.04M | 0.67% | 33 |
|
|
2015
Q2 | $28.4M | Sell |
322,329
-17,423
| -5% | -$1.6M | 0.77% | 25 |
|
|
2015
Q1 | $30M | Sell |
339,752
-40,634
| -11% | -$3.6M | 0.86% | 19 |
|
|
2014
Q4 | $31.6M | Sell |
380,386
-5,559
| -1% | -$461K | 0.93% | 17 |
|
|
2014
Q3 | $32.6M | Sell |
385,945
-13,580
| -3% | -$1.1M | 0.98% | 15 |
|
|
2014
Q2 | $32.4M | Sell |
399,525
-14,290
| -3% | -$1.12M | 0.97% | 13 |
|
|
2014
Q1 | $31.5M | Sell |
413,815
-3,206
| -0.8% | -$234K | 0.99% | 13 |
|
|
2013
Q4 | $30M | Buy |
417,021
+9,308
| +2% | +$647K | 0.97% | 14 |
|
|
2013
Q3 | $28M | Buy |
407,713
+9,959
| +3% | +$659K | 0.99% | 14 |
|
|
2013
Q2 | $25.2M | Buy |
+397,754
| New | +$25.9M | 0.94% | 17 |
|
Other funds holding NVS
Truist Financial's NVS Position: Q1 2026 in Review
Truist Financial increased its Novartis (NVS) stake by 6.1% in Q1 2026, buying an estimated $8.36M and bringing the position to 941,818 shares worth $144M. The position accounts for 0.19% of the portfolio, ranked #103.
Truist Financial first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Truist Financial held 941,818 shares of Novartis worth $144M as of Q1 2026.
- Truist Financial bought 54,522 Novartis shares in Q1 2026, an estimated $8.36M.
- Novartis made up 0.19% of Truist Financial's portfolio in Q1 2026, its #103 holding.
- Truist Financial first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.